Back to search

University of Thessaly (UTH)

Διερεύνηση της οστικής πυκνότητας, της σύστασης μάζας σώματος και των δεικτών του οστικού μεταβολισμού σε ελληνικό πληθυσμό με ομόζυγη Μεσογειακή Αναιμία

Abstract

dc:description

Patients with thalassemia develop a multifactorial bone disorder with the predominant cause being hyperplasia of the red marrow that occupies the medullary cavities and causes a disturbance of the bone microarchitecture and refinement of the cortical part. Histologically, these patients present with a range of osteopenia to osteoporosis and are prone to fractures. Bone density (BMD) assessment in patients with thalassemia is more important as patients have a longer life expectancy. The DXA method and quantitative computed tomography (QCT) are acceptable methods for assessing BMD. DXA is more popular and is referred to as the preferred method. Due to its lower radiation exposure, ease of access and speed of performance, it is the "gold standard" method of choice for measuring bone density, especially in children. However, DXA measurements are two-dimensional and do not provide information on bone architecture, with QCT describing BMD per unit bone mass, estimating all three dimensions of bone, and distinguishing between cortical and spongy bone. of bone. QCT allows a clear distinction between the effects on bone size and density. DXA is unable to visualize changes at a three-dimensional level, leading to underestimation of BMD in smaller bones. The QCT method is accepted as a reliable, accurate and simple method of assessing osteoporosis. Although QCT is still a widely used technique in many centers, especially for postmenopausal patients with osteoporosis, knowledge about the accuracy of bone mass measurement methods in different clinical conditions is very limited. The most frequently reported clinical event is the fatty tranformation of the bone marrow, which leads to an underestimation of the amount of bone mass in elderly patients. The determination of BMD in patients with thalassemia depends on the technique used. There is disagreement in the literature about the value of DXA or QCT in this patient population. Using the number of trabeculae as an indicator of osteoporosis, it appears that QCT could evaluate bone disease better than DXA, as the method has the ability to measure spongy and cortical bone density separately. However, red marrow hyperplasia on the one hand and iron deposition in the bone marrow complicates the picture and BMD is often overestimated. Though, these findings suggest that the two methods may not be used interchangeably in the assessment of BMD in patients with thalassemia. Which of these two techniques accurately determines the overall strength of the vertebrae, which is also clinically required, in patients with β-thalassemia, needs to be investigated. The need for studies to assess bone density with a variety of and / or innovative methods in the same patient and in a control group, aims to draw conclusions that are related not only to the change in quantity but also to the microarchitecture of bone in various positions. This will possibly address problems related to the two-dimensional imaging and projections of bone structures that distort the true value of bone mass. In addition, separate data will be obtained for cortical and spongy bone, as these two types respond differently to changes in bone metabolism. Moreover, body mass composition is affected by many parameters such as age, gender, endocrine system status, diet and exercise. It is known that the above parameters are disturbed in patients with thalassemia major in addition to bone marrow hyperplasia, iron overload and reduced bone density. However, there are limited published data on the state of body composition in this population, especially in adulthood. Lean mass has been shown to be highly correlated with bone density until middle age when adipose tissue mass begins to represent the largest percentage. The DXA method has been reported as a reliable method for evaluating body mass composition in various patient groups, including thalassemia. The present study aims to contribute to filling this gap in the literature and to assist in clinical applications that improve the quality of life of patients with thalassemia.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Alexiou, Evangelos
  • Αλεξίου, Ευάγγελος

Subjects

dc:subject × 15

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/50776

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Alexiou, Evangelos; Αλεξίου, Ευάγγελος. Διερεύνηση της οστικής πυκνότητας, της σύστασης μάζας σώματος και των δεικτών του οστικού μεταβολισμού σε ελληνικό πληθυσμό με ομόζυγη Μεσογειακή Αναιμία. University of Thessaly (UTH), 2021. http://hdl.handle.net/10442/hedi/50776